Conceptio › Archive › HAL (France)
HAL (France)open access

An adaptive, biomarker-directed platform study of durvalumab in combination with targeted therapies in advanced urothelial cancer

Thomas Powles et al.
HAL (France) · Papers · License: Open Access
Open Source ↗
0
This document is indexed with metadata only — full text is not available in the archive for this record. Open the official source ↗

Related documents

Record · ID 669975
Retrieved via Conceptio — every document is proof-bundled with source, license, and retrieval metadata.